Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,906 | 38,753 | 96,339 | 24,487 | 42,748 |
| Marketable Securities | N/A | N/A | N/A | 54,590 | 46,221 |
| Other current assets | 2,853 | 2,276 | 1,968 | 1,211 | 396 |
| TOTAL | $52,112 | $44,206 | $102,183 | $83,608 | $91,895 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 0 | 32,459 |
| Other Non-Current Assets | 909 | 1,003 | 1,763 | 2,040 | 2,132 |
| TOTAL | $909 | $1,003 | $1,763 | $2,040 | $34,591 |
| Total Assets | $53,021 | $45,209 | $103,946 | $85,648 | $126,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,622 | 1,622 | 1,622 | N/A |
| Accounts payable and accrued liabilities | 943 | 1,295 | 3,332 | 1,426 | 2,823 |
| Accrued Expenses | 9,143 | 12,329 | 14,600 | 9,399 | 6,048 |
| TOTAL | $10,086 | $15,246 | $24,465 | $12,447 | $8,871 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 124 | 1,717 | 3,293 | 4,878 |
| Deferred Revenues | N/A | N/A | 4,911 | N/A | N/A |
| Other Non-Current Liabilities | 419 | 1,018 | 1,255 | 1,422 | 1,366 |
| TOTAL | $419 | $1,142 | $2,972 | $4,715 | $6,244 |
| Total Liabilities | $10,505 | $16,388 | $27,437 | $17,162 | $15,115 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,372 | 562 | 547 | 529 | 312 |
| Common Shares | N/A | N/A | 4 | 3 | 3 |
| Retained earnings | -289,234 | -250,268 | -197,232 | -149,313 | -103,133 |
| Other shareholders' equity | 0 | 0 | 0 | -558 | -184 |
| TOTAL | $42,516 | $28,821 | $76,509 | $68,486 | $111,371 |
| Total Liabilities And Equity | $53,021 | $45,209 | $103,946 | $85,648 | $126,486 |